Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lefer

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Circulation Research|February 18, 2021
Demystifying Cardiac Aging: Still Much to LearnZhen Li, David J Lefer
American Heart Journal|July 2, 2005
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriersDaniel Burkhoff, David J Lefer
Experimental Physiology|August 26, 2011
Emerging roles for gasotransmittersChris Peers, David J Lefer
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto Bolli
Journal of Cardiovascular Translational Research|July 15, 2010
Development of hydrogen sulfide-based therapeutics for cardiovascular diseaseBenjamin L Predmore, David J Lefer
Expert Review of Clinical Pharmacology|March 5, 2011
Hydrogen sulfide-mediated myocardial pre- and post-conditioningBenjamin L Predmore, David J Lefer
Physiology (Bethesda, Md.)|July 3, 2013
Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotectionJohn W Calvert, David J Lefer
Cardiovascular Research|November 17, 2007
Thrombopoietin emerges as a new haematopoietic cytokine that confers cardioprotection against acute myocardial infarctionJohn W Calvert, David J Lefer
Experimental Physiology|June 14, 2011
Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injuryAdrienne L King, David J Lefer
Drug News & Perspectives|July 22, 2005
The effects of statins on endothelium, inflammation and cardioprotectionJohn W Elrod, David J Lefer
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Circulation Research|February 18, 2021
Demystifying Cardiac Aging: Still Much to LearnZhen Li, David J Lefer
American Heart Journal|July 2, 2005
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriersDaniel Burkhoff, David J Lefer
Experimental Physiology|August 26, 2011
Emerging roles for gasotransmittersChris Peers, David J Lefer
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto Bolli
Journal of Cardiovascular Translational Research|July 15, 2010
Development of hydrogen sulfide-based therapeutics for cardiovascular diseaseBenjamin L Predmore, David J Lefer
Expert Review of Clinical Pharmacology|March 5, 2011
Hydrogen sulfide-mediated myocardial pre- and post-conditioningBenjamin L Predmore, David J Lefer
Physiology (Bethesda, Md.)|July 3, 2013
Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotectionJohn W Calvert, David J Lefer
Cardiovascular Research|November 17, 2007
Thrombopoietin emerges as a new haematopoietic cytokine that confers cardioprotection against acute myocardial infarctionJohn W Calvert, David J Lefer
Experimental Physiology|June 14, 2011
Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injuryAdrienne L King, David J Lefer
Drug News & Perspectives|July 22, 2005
The effects of statins on endothelium, inflammation and cardioprotectionJohn W Elrod, David J Lefer
Pageof 19